Annalisa Bramati

Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients

Annamaria Ruzzo, Francesco Graziano, Fabio Galli et al. · British Journal of Cancer · 2017 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17

Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients

Annamaria Ruzzo, Francesco Graziano, Fabio Galli et al. · Scientific Reports · 2014 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

The prognostic role of tumor size in early breast cancer in the era of molecular biology

Anaid Anna Kasangian, Giorgio Gherardi, Elena Biagioli et al. · PLoS ONE · 2017 · 42 citations · Full text

Medicine, Oncology, Surgery +14

Prospective, mono-institutional study of the impact of a systematic prevention program on incidence and outcome of osteonecrosis of the jaw in patients treated with bisphosphonates for bone metastases

Annalisa Bramati, Serena Girelli, Gabriella Farina et al. · Journal of Bone and Mineral Metabolism · 2014 · 41 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +13

Randomised Phase II Trial (NCT00637975) Evaluating Activity and Toxicity of Two Different Escalating Strategies for Pregabalin and Oxycodone Combination Therapy for Neuropathic Pain in Cancer Patients

Marina Chiara Garassino, Sheila Piva, Nicla La Verde et al. · PLoS ONE · 2013 · 31 citations · Full text

Nursing, Pharmacology, Pharmacotherapy +17